A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer
Clinical trial NCT00320541 · COMPLETED
Trial details
- NCT number
- NCT00320541
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2009-04-01
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.